Alpha Sense BI

MAY 5, 2023

With the current heavy focus on value-based care—a medical philosophy that focuses on improving outcomes and reducing costs for patients—many hospitals and health systems are merging to gain scale, reduce costs, improve their negotiating power with payers and suppliers, and gain the ability to invest in new technologies and services.

Biotech 97

Biotech Capital Banking Startups 97

Alpha Sense BI

SEPTEMBER 15, 2023

By expanding from their core offering of medical devices to broader healthcare services and solutions, Medtronic was able to get a bigger stake in a patient’s health journey, while providing meaningful clinical and economic value for hospitals.

Hospitals 105

Hospitals Due Diligence Innovation Globalization 105

Alpha Sense BI

OCTOBER 6, 2023

Opportunities abound for innovative medical device companies that can create a wearable or biometric device that provides value to consumers, while easing pressure on hospitals and healthcare facilities. This practice can reduce hospital costs by up to 50% and cut ozone depletion by almost 90%.

Hospitals 59

Hospitals Startups Due Diligence Innovation 59

Alpha Sense BI

APRIL 12, 2024

Expert interviews are a critical primary research tool that financial professionals often leverage to complete their investment process with last-mile, experiential insights. Soft Data – Investment researchers often use soft market data to add qualitative context to numerical data and create a comprehensive view of any research topic.

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

MARCH 13, 2024

Hospital and health system deal activity increased 27% year over year in 2023 , and a flurry of deals has been announced since the beginning of the year. The ability to bring drugs and therapies to market sooner, with less intrinsic cost, ultimately leads to stronger valuations and greater stakeholder value.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59